Related Experiment Video
Updated: Jan 11, 2026

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
Published on: September 19, 2018
Network centric identification of PI3K/Akt hub proteins as key oncogenic drivers and therapeutic targets
1Department of Mathematics & Statistics, College of Science, King Faisal University, P. O. Box 400, Al-Ahsa, 31982, Saudi Arabia. efadhal@kfu.edu.sa.
Abstract:
The PI3K/Akt pathway plays a central role in cancer progression by regulating cell proliferation, survival, and metabolism. Dysregulation of this pathway, often due to mutations in genes such as PIK3CA, PTPN11, EGFR, and AKT1, contributes to tumorigenesis and therapy resistance. Using a network metric space approach, we systematically analyzed the human protein-protein interaction network to identify key hub proteins. Our findings suggest that signaling proteins dominate the PI3K/Akt pathway (100%), with significant overlaps in MAPK cascades (29.1%) and essential oncogenic drivers (70.8%), indicating potential co-targeting strategies to overcome resistance. Functional enrichment analysis highlights the therapeutic relevance of these hubs, while 5.8% of identified proteins are oncogenes, reinforcing their candidacy for therapies. This study provides a systematic, network-based framework for identifying and prioritizing hub proteins in the PI3K/Akt pathway, with potential implications for rational multi-target drug design in precision oncology.
Insights
This study identifies key signaling proteins in the PI3K/Akt pathway using network analysis. Findings suggest co-targeting strategies to overcome cancer therapy resistance and inform precision oncology drug design.
Area of Science:
- Oncology
- Systems Biology
- Bioinformatics
Background:
- The PI3K/Akt pathway is crucial for cancer cell proliferation, survival, and metabolism.
- Pathway dysregulation, driven by mutations in genes like PIK3CA and AKT1, promotes tumorigenesis and therapy resistance.
Purpose of the Study:
- To systematically identify key hub proteins within the human PI3K/Akt protein-protein interaction network.
- To explore potential co-targeting strategies for overcoming cancer therapy resistance.
Main Methods:
- Network metric space approach applied to the human protein-protein interaction network.
- Systematic analysis to identify key hub proteins within the PI3K/Akt pathway.
- Functional enrichment analysis and oncogene identification.
Main Results:
- Signaling proteins constitute 100% of identified PI3K/Akt pathway hubs.
- Significant overlaps were found with MAPK cascades (29.1%) and essential oncogenic drivers (70.8%).
- 5.8% of identified proteins are classified as oncogenes, highlighting therapeutic relevance.
Conclusions:
- A systematic, network-based framework for identifying and prioritizing PI3K/Akt pathway hub proteins.
- Potential for rational multi-target drug design in precision oncology to combat therapy resistance.
More Related Videos
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The JAK-STAT Signaling Pathway
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation